This study demonstrated that protocatechuic acid treatment alleviates cardiac hypertrophy, fibrosis, oxidative stress, and dysfunction in an isoproterenol‐induced heart failure mouse model by downregulating Kmo (Figure 8G). This evidence concerns the gene KMO and heart failure.